| Literature DB >> 35494766 |
Ahmad Mobed1,2,3, Mohammad Hasanzadeh3,4, Farzad Seidi5.
Abstract
Gold nanocomposites are being widely used in numerous biomedical applications owing to their excellent stability and miniaturization. Gold nanocomposites are notable because of their flexibility of functionalization and synthesis, ease of detection, and low toxicity. Cost-effectiveness, long-term stability, non-cytotoxicity, and biocompatibility are the main aspects of ideal nanocomposites. Antibacterial nanocomposites are being developed extensively in the food industry, environmental applications, and biological and medical devices. This review focuses on the applications of metal-based nanoparticles, mainly gold nanoparticles (AuNPs), as antibacterial agents in medical approaches. Additionally, the antibacterial mechanisms of AuNPs and their roles in fighting antibiotic-resistant microorganisms are highlighted in the present review. This journal is © The Royal Society of Chemistry.Entities:
Year: 2021 PMID: 35494766 PMCID: PMC9042813 DOI: 10.1039/d1ra06030a
Source DB: PubMed Journal: RSC Adv ISSN: 2046-2069 Impact factor: 4.036
Antibacterial properties of some important metal-based nanocomposites
| Nanocomposites | Bacteria | Mechanisms | Ref. |
|---|---|---|---|
| ZnO–Ag NPs |
| Increases bacterial cell membrane permeability |
|
| CuO–Ag NPs |
| Rupture of the plasma membrane, cell wall damage, disturbs biochemical process |
|
| Cu-doped TiO2 NPs |
| Reduced enzymatic activity, release of Cu2+, changes in NADPH production |
|
| Ag NPs |
| Adsorption, and penetration of NPs and toxicity with electrostatic interaction |
|
| ZnO NPs |
| Membrane disruption, ROS generation, and disturbance of permeability |
|
| Al2O3 |
| Electrostatic interaction and altered bacterial attachment, damage to the bacterial cell wall and increased permeability |
|
| NiO NPs |
| Growth inhibition, particularly in aqueous medium, physical and mechanical stresses on cellular structure integrity and major damage to cellular functions |
|
| TiO2 |
| Frameshift mutation, ROS generation |
|
| Ag |
| Disturbed permeability and cell division, interacts with cell membrane and sulfur- and phosphorus-containing-compounds |
|
Fig. 1Shapes and size of gold nanoparticles.[26]
Fig. 2Schematic diagram of antibacterial activity of AuNPs against E. coli.[26]
Fig. 3Antibacterial activity of AuNPs against S. pneumoniae.[48]
Fig. 4Main molecular mechanisms of AuNP antibacterial activities.
Molecular mechanisms of metal-based nanoparticle antibacterial activity
| NPs | Molecular mechanisms | Ref. |
|---|---|---|
| Ag | Inhibiting DNA replication, damaging the cell membrane, and inactivation of proteins |
|
| Ag | Affecting the purine metabolite pathway is another antibacterial mechanism |
|
| Ag | Makes penetration through cell membrane easier, cooperating with intracellular materials and allowing cell destruction |
|
| TiO2/ZnO | Reactive oxygen species (ROS) aid as cell signaling molecules for regular biological processes and damage many cellular and molecular processes |
|
| C-based | Mechanical damage or apply oxidant |
|
| AuNPs | AuNPs target the energy metabolism and transcription process of bacteria |
|
| AuNPs | Formation of IB-AuNPs, and disruption of the bacterial cell membrane |
|
Fig. 5Schematic illustration of the preparation of UsAuNPs/MOFs hybrid for antibacterial therapy.[58]
Fig. 6Schematic illustration of nanocomposite preparation for antibacterial activity.[60]
Fig. 7A schematic image of the antibacterial mechanism of TNTs/Au/CDs under 808 nm NIR light irradiation within 15 min.[65]
Fig. 8Schematic illustration of the antibacterial activity of synthesized trimetallic nanocomposites.[80]
Antibacterial activity of AuNPs in some studiesa
| Nanocomposites | Bacteria | Synthesis method | Application | Ref. |
|---|---|---|---|---|
| AuNPs |
| Green synthesis method | Environmental/biological |
|
| UsAuNPs/MOFs hybrid |
| Hydrothermal | Wound healing, clinical |
|
| Au, Ag, and Pd nanoparticles-carbon composite | Gram-negative bacterial strains | Green synthesis method | Electrochemical energy storage applications |
|
| MnFe2O4@SiO2@Au |
| Ultrasound-assisted precipitation | Treatment of bacterial and fungal diseases |
|
| Au@Bi2S3 |
| Schottky junction | Environmental remedy and medical treatment |
|
| PDMS-ZnO/Au |
| Photo-reduction protocol/hydrothermal | Biological contamination for catheter, medical paint, and implant tools |
|
| AuNPs-COOH/AgNO3 |
| Seeding method | Nanomedicine engineering |
|
| TNTs/Au/CDs |
| NA | Public health and medical disinfection |
|
| Ag–Au/CeO2 |
| Ionic liquid functionalized green synthesized | Biological |
|
| Au–Pt |
| Co-reduction | Clinical |
|
| Titania/TiO2 |
| Hydrothermal method | Marine antifouling paint sewage and treatment |
|
| Au/TiO2 |
| NA | Biological |
|
| Fe3O4–Au NCs | Gram-positive and Gram-negative pathogens | Reduction method | Water samples, pharmaceutical and medical applications |
|
| CML@X-NPs, X = Ag, Au |
| Green synthesis | Biological, clinical |
|
| ZMS-Au |
| Layer-by-layer self-assembly | Environmental protection |
|
| Au@TiO2-NT |
| NA | Orthopedic devices and implants |
|
| Propane-1,2,3-triol and Ag/AuNPs |
| Size-controlled synthesis | Environmental |
|
| Au/Ag alloy nanoparticles using |
| NA | Biological fields |
|
| GO@Au@Ag |
| NA | Environmental |
|
| GPA NPs | Biofilms and intracellular bacteria | Green synthesis | Treatment of chronic infections |
|
| Watermelon extract-AuNPs |
| Biogenic synthesis | Pharmaceutical applications |
|
| Au/TiO2 |
| Solvothermal method | Biological fields |
|
| Trimetallic Au/Pt/Ag | Some microorganisms | Chemical reduction method | Pharmaceutical applications, environmental and medical |
|
| TiO2–Au | Bacterial adhesion and biofilm | NA | Orthopedic and dental implants |
|
| Silicone-Au-Mb |
| Swell-encapsulation-shrink | NA |
|
| Cellulose paper-Au-AgNPs |
| NA | Wound dressings, food packaging, personal care products and clothing |
|
| TiO2@ZnO |
| NA | Biological applications |
|
| LPB-AuNPs | Gram-positive and 4 Gram-negative bacterial strains | NA | Biological applications |
|
| Aragonite-AuNPs | Gram-negative | Hydrothermal synthesis | Medical application |
|
| CS–AuNPs | Methicillin–resistant | Co-reduction | Medical application |
|
| (α-Fe2O3)-AuNPs |
| Hydrothermal | Wastewater remediation applications |
|
| Ag/AuNPs |
| Citrate-capped nanoparticle synthesis | Biological, clinical |
|
| Ag/AuNPs | Antibiotic-resistant bacteria and | Green synthesis | Pharmaceutical applications, environmental and medical |
|
| AuNPs |
| Green synthesis | Cell line studies, pharmaceutical applications |
|
| Ag/Pt, Ag/Ir, Ag/PtIr, Au/Pt, Au/Ir, and Au/PtIr |
| MOCVD | Pharmaceutical and medical applications |
|
| AuNPs-EGCG |
| Green synthesis | Biomedical and biological |
|
NA: not available, (UsAuNPs/MOFs hybrid): ultra-small AuNPs/metal–organic frameworks, (PDMS-ZnO/Au): polydimethylsiloxane, (Fe3O4–Au NCs): iron oxide gold nanocomposites, (CML@X-NPs, X = Ag, Au): Crataegus monogyna leaf extract with gold nanoparticles, (LPB): lipopeptide biosurfactant, (CS–AuNPs): chitosan–gold hybrid nanoparticles, (MOCVD): metal–organic chemical vapor deposition, (EGCG): epigallocatechin 3-gallate.